Peptide-Based Cancer Vaccines
Abstract The application of molecularly defined vaccines composed of a limited number of tumor-specific T cell epitopes has resulted in protective intitumor T cell innumity in several mouse tumor models. The first encouraging results with such vaccines have been obtained in human beings. The development of the next generation of rationally designed vaccines that are both effective and safe for application in a clinical setting requires comparison of different modes of delivery of tumor-associated T cell epitopes in multiple epitope constructs
{{comment.content}}
隐私声明 | 电子书 | 出版社
主办单位:中国教育图书进出口有限公司
京ICP备11007853号-12 
京公网安备 11010802027623号
Copyright ©爱学术平台 2021, All Rights Reserved